Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading ->
A newly identified microbe, named Microsporidia MB, can prevent mosquitoes from being infected by malaria parasites. This microbe could be used to block the transmission of malaria parasites from mosquito vectors to humans, according to new research published by researchers from the International Centre of Insect Physiology and Ecology (icipe) in Kenya and the University […] Continue reading ->
Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading ->
The combined impact of Covid-19 and malaria in regions where malaria is widespread “could be catastrophic,” warned David Reddy, CEO of Medicines for Malaria Venture (MMV), the Geneva-based product development partnership, just ahead of World Malaria Day, which is celebrated on Saturday, 25 April. His commment to Health Policy Watch,  came in the wake of […] Continue reading ->
US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch.  There are some 23,000 GeneXpert […] Continue reading ->
[Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading ->